pyrroles has been researched along with Salivary Gland Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, LZ; Liang, YJ; Liao, GQ; Liu, HC; Ma, B; Su, YX; Zhang, TH; Zheng, GS | 1 |
| Chau, NG; Chen, EX; Chin, SF; Hotte, SJ; Siu, LL; Turner, S; Wang, L | 1 |
1 trial(s) available for pyrroles and Salivary Gland Neoplasms
| Article | Year |
|---|---|
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Adenoid Cystic; Disease-Free Survival; Female; Humans; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Proto-Oncogene Mas; Pyrroles; Salivary Gland Neoplasms; Sunitinib; Treatment Outcome | 2012 |
1 other study(ies) available for pyrroles and Salivary Gland Neoplasms
| Article | Year |
|---|---|
Obatoclax induces Beclin 1- and ATG5-dependent apoptosis and autophagy in adenoid cystic carcinoma cells.
Topics: Autophagy; Autophagy-Related Protein 5; Beclin-1; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Survival; Humans; Indoles; Prognosis; Pyrroles; Salivary Gland Neoplasms | 2015 |